STOCK TITAN

Alexander's (ALX) Financials

ALX
Trailing 12 months to June 30, 2026
Revenue $214.8M -1.5% YoY
Net Income $169.8M +354.2% YoY
EPS (Diluted) $33.06 +354.1% YoY
Operating Cash Flow $27.2M -68.1% YoY
Market Cap $1.3B as of Sep 3, 2026
Price / Sales 6.3x on $214.8M revenue, trailing 12 months to June 30, 2026
Price / Earnings 7.9x on $169.8M net income, trailing 12 months to June 30, 2026
Price / Book 6.0x on $223.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALX SEC filings page.

Alexander's (ALX) reported $214.8M in revenue over the twelve months to Jun 30, 2026, down 1.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALX FY2025

Alexander’s operates through a shrinking equity base: heavy leverage and dividends absorb cash despite positive operating cash generation.

By FY2025, equity had more than halved since FY2023 while debt-to-equity reached 9.2x, showing that the balance sheet became progressively more debt-dependent even as assets contracted. Operating cash flow was $74.4M, yet dividends were $92.4M; cash generated by operations therefore did not fully fund the recurring distribution.

Revenue fell 5.8% in FY2025 as net profit margin narrowed to 13.2%; the latest weakness reflects both a softer top line and less earnings retained per dollar, rather than volume alone. With gross and operating margins unavailable, net margin is the clearest earnings-efficiency signal in these tables.

Depreciation and amortization was $38.1M versus net income of $28.2M, helping explain why operating cash flow exceeded reported profit despite low accounting earnings. Financing cash flow was -$254.3M, far larger than the dividend payment, indicating that FY2025’s cash movement involved substantial capital-structure activity beyond routine distributions.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

FFO Margin FFOGrowth Leverage Interest Cov. AFFOMargin DividendCov. 26 / 100
Financial Health Score 26/100
Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Alexander's's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin
62

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Alexander's scores 62/100 on it among other REITs.

FFO Growth
10

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Alexander's scores 10/100 on it among other REITs.

Leverage
0

Not available for Alexander's, and counted as zero in the overall score.

Interest Cov.
0

Not available for Alexander's, and counted as zero in the overall score.

AFFO Margin
66

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Alexander's scores 66/100 on it among other REITs.

Dividend Cov.
16

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Alexander's scores 16/100 on it among other REITs.

Piotroski F-Score Partial
5/6

Alexander's passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
2.60x

For every $1 of reported earnings, Alexander's generates $2.60 in operating cash flow ($73.4M OCF vs $28.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$54.7M
YoY+6.1%
QoQ+2.4%
5Y CAGR+1.3%

Alexander's generated $54.7M in revenue in Q2 2026. This represents an increase of 6.1% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Net Income
$155.4M
YoY+2438.6%
QoQ+3232.5%
5Y CAGR+43.1%
10Y CAGR+21.7%

Alexander's reported $155.4M in net income in Q2 2026. This represents an increase of 2438.6% from the same quarter a year earlier. Against the prior quarter it is up 3232.5%.

EPS (Diluted)
$30.24
YoY+2441.2%
QoQ+3223.1%
5Y CAGR+43.0%

Alexander's earned $30.24 per diluted share (EPS) in Q2 2026. This represents an increase of 2441.2% from the same quarter a year earlier. Against the prior quarter it is up 3223.1%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$303.3M
YoY-3.1%
QoQ+297.8%
5Y CAGR-7.5%
10Y CAGR+2.6%

Alexander's held $303.3M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share
$4.50
YoY0.0%
QoQ0.0%
5Y CAGR0.0%

Alexander's paid $4.50 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
5M
YoY0.0%
QoQ0.0%
5Y CAGR0.0%
10Y CAGR0.0%

Alexander's had 5M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Return on Equity
69.5%
YoY+65.3pp
QoQ+64.3pp
5Y CAGR+56.9pp
10Y CAGR+63.4pp

Alexander's's ROE was 69.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 65.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 64.3 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not shown for Q2 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q2 2026.

ALX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALX quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$54.7M+6.1%$53.4M-2.7%$53.3M-4.7%$53.4M-4.0%$51.6M-3.4%$54.9M-10.6%$55.9M-11.2%$55.7M+0.5%
SG&A Expenses$3.3M+67.1%$1.7M+7.7%$1.7M+13.6%$1.3M-5.2%$2.0M-9.4%$1.6M+7.8%$1.5M-2.3%$1.4M-9.9%
Interest Expense$10.8M-15.7%$10.7M-0.6%$14.0M+25.6%$14.1M-26.9%$12.8M-21.1%$10.8M-33.5%$11.1M-33.4%$19.3M+19.1%
Net Income$155.4M+2438.6%$4.7M-62.1%$3.8M-68.9%$6.0M-10.6%$6.1M-27.0%$12.3M-23.6%$12.3M-24.6%$6.7M-37.9%
EPS (Basic)$30.24+2441.2%$0.91-62.1%$0.75-68.6%$1.16-10.8%$1.19-27.0%$2.40-23.6%$2.39-24.8%$1.30-38.1%
EPS (Diluted)$30.24+2441.2%$0.91-62.1%$0.75-68.6%$1.16-10.8%$1.19-27.0%$2.40-23.6%$2.39-24.8%$1.30-38.1%
Diluted Shares (Avg)5M+0.1%5M0.0%N/A5M0.0%5M+0.1%5M+0.1%N/A5M+0.1%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.

ALX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALX quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$1.2B-8.9%$1.1B-17.8%$1.1B-17.2%$1.3B-5.0%$1.3B-10.8%$1.3B-4.2%$1.3B-4.4%$1.4B-3.3%
Cash & Equivalents$303.3M-3.1%$76.2M-76.2%$128.2M-62.1%$286.1M-19.4%$313.0M-23.8%$319.9M-39.2%$338.5M-36.3%$354.8M-30.1%
Short-Term Investments$0$0$0$0$0$0$0$0
Accounts Receivable$3.0M-27.4%$2.5M-52.9%$4.1M-19.6%$4.3M-8.6%$4.1M-10.1%$5.4M-6.4%$5.1M-15.9%$4.7M-26.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$979.4M-16.7%$1.0B-14.0%$1.0B-14.0%$1.2B-0.5%$1.2B-7.3%$1.2B+0.7%$1.2B-0.1%$1.2B+1.3%
Total Equity$223.6M+53.7%$90.7M-44.4%$109.2M-38.3%$128.3M-32.7%$145.4M-31.6%$163.1M-29.1%$176.9M-25.6%$190.7M-24.3%
Retained Earnings$183.0M+73.2%$50.8M-58.6%$69.2M-48.1%$88.5M-38.6%$105.6M-34.2%$122.6M-30.1%$133.4M-26.8%$144.2M-23.7%

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

ALX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALX quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$6.2M-85.8%$6.8M-56.6%$23.4M-24.0%-$9.3M-84.2%$43.6M+278.8%$15.7M-6.6%$30.8M-31.1%-$5.0M-226.3%
Depreciation & Amortization$8.2M-5.5%$9.4M+0.3%$9.4M+0.1%$9.0M+13.1%$8.7M+0.1%$9.4M-5.3%$9.4M-2.8%$8.0M+0.5%
Investing Cash Flow$223.2M+3475.9%-$23.9M-197.7%-$1.8M+81.9%-$4.4M-19.1%-$6.6M-2075.0%-$8.0M-1270.9%-$9.9M-537.3%-$3.7M-470.2%
Financing Cash Flow-$23.1M+4.9%-$23.1M+3.3%-$181.7M-650.6%-$24.4M+79.4%-$24.3M+29.0%-$23.9M-3.5%-$24.2M-4.7%-$118.5M-412.6%
Dividends Paid$23.1M0.0%$23.1M0.0%$23.1M0.0%$23.1M0.0%$23.1M+0.1%$23.1M+0.1%$23.1M+0.1%$23.1M+0.1%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

ALX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALX quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin284.0%8.7%-13.7pp7.2%-14.8pp11.2%-0.8pp11.9%-3.8pp22.4%-3.8pp22.0%-3.9pp12.0%-7.4pp
Return on Equity69.5%+65.3pp5.1%-2.4pp3.5%-3.4pp4.7%+1.1pp4.2%+0.3pp7.5%+0.5pp6.9%+0.1pp3.5%-0.8pp
Return on Assets12.9%+12.4pp0.4%-0.5pp0.3%-0.6pp0.5%0.0pp0.5%-0.1pp0.9%-0.2pp0.9%-0.2pp0.5%-0.3pp
Debt-to-Equity4.38-3.7x11.08+3.9x9.18+2.6x9.10+2.9x8.08+2.1x7.17+2.1x6.58+1.7x6.16+1.6x
Asset Turnover0.050.0x0.050.0x0.050.0x0.040.0x0.040.0x0.040.0x0.040.0x0.040.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Alexander's ALX FY2025 $213.2M $28.2M 13.2% $1.3B 26/100
Alexander & Baldwin Inc ALEX FY2025 $206.7M $64.7M 31.3% $1.5B 65/100
Saul Ctrs Inc BFS FY2025 $289.8M $37.5M 12.9% $806.8M 62/100
Cbl & Assoc Pptys Inc CBL FY2025 $578.4M $136.0M 23.5% $1.7B 53/100
Getty Rlty Corp GTY FY2025 $221.7M $79.2M 35.7% $2.0B 68/100
Netstreit Corp NTST FY2025 $195.0M $6.9M 3.6% $2.1B 51/100

Frequently Asked Questions

What is Alexander's's annual revenue?

Alexander's (ALX) reported $213.2M in total revenue for fiscal year 2025. This represents a -5.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Alexander's's revenue growing?

Alexander's (ALX) revenue declined by 5.8% year-over-year, from $226.4M to $213.2M in fiscal year 2025.

Is Alexander's profitable?

Yes, Alexander's (ALX) reported a net income of $28.2M in fiscal year 2025, with a net profit margin of 13.2%.

Alexander's (ALX) reported diluted earnings per share of $5.50 for fiscal year 2025. This represents a -35.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Alexander's (ALX) had a net profit margin of 13.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Alexander's (ALX) paid $18.00 per share in dividends during fiscal year 2025.

Alexander's (ALX) has a return on equity of 25.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Alexander's (ALX) generated $73.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Alexander's (ALX) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Alexander's (ALX) had 5M shares outstanding as of fiscal year 2025.

Alexander's (ALX) had a debt-to-equity ratio of 9.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Alexander's (ALX) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Alexander's (ALX) trades at 7.9x earnings, its market capitalization divided by net income of $169.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.3B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Alexander's (ALX) trades at 6.3x sales, its market capitalization divided by revenue of $214.8M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.3B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Alexander's (ALX) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Alexander's (ALX) has an earnings quality ratio of 2.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Alexander's (ALX) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top